by Caleb Horst | Aug 7, 2019 | In The Lab
Synthetic grafts have been used since the 1970s to treat cardiovascular diseases. Although autologous arteries or veins are preferred, conditions such as low patency rates and compliance mismatch tend to lead to graft failure. Tissue-engineered vascular grafts (TEVGs)...
by Caleb Horst | Jul 25, 2019 | In The Lab
Proton-Exchange Membrane Fuel Cells is a favourable alternative to the internal combustion engines in vehicle applications. It was initially developed by General Electric for NASA for use in the Gemini spacecraft (ScienceDirect). In this system, thin, conductive...
by Caleb Horst | Jul 8, 2019 | In The Lab
Bottom-up bioengineering is an approach to build tissue structures using cell-laden modules (such as extracellular matrix) as opposed to seeding cells into porous scaffolds. It has a higher level of biomimicry and has been used successfully in clinical settings for...
by Caleb Horst | Jul 4, 2019 | In The Lab
A jugular venous valve functions to prevent retrograde blood flow. If it malfunctions or is incompetent, symptoms such as amnesia or stroke may occur. Moreover, there are no long-term remedy for jugular venous valve incompetence – surgery to replace a failed...
by Caleb Horst | Jul 4, 2019 | In The Lab
In the field of biosensors, artificial muscles and microfluidics, shape-morphing hydrogels are of significant interest. Isotropic materials can be morphed into complex shapes under aqueous stimuli by varying the material (embedding with stiff particulate such as...
by Caleb Horst | May 27, 2019 | In The Lab
Corneal Ectasia occurs when there are irregularities in the cornea which may lead to disturbances of vision. Astigmatism is a common outcome of corneal ectasia, but the disorder can also occur after refractive surgery (LASIK). It is the second leading cause of corneal...